Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyoun-Ah Kim

Showing results (61-70 of 171) with videos related to

Pageof 18
Sort By:
Rheumatology International|March 31, 2010
Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosusHyoun-Ah Kim, Jun-Mo Sung, Ja-Young Jeon, et al.
The Journal of Rheumatology|September 17, 2009
C-reactive protein gene polymorphisms in disease susceptibility and clinical manifestations of Korean systemic lupus erythematosusHyoun-Ah Kim, Hye-Young Chun, Seung-Hyun Kim, et al.
Scientific Reports|December 8, 2019
Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosusWook-Young Baek, Ji-Min Woo, Hyoun-Ah Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 29, 2022
Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO RegistryJi-Won Kim, Eunyoung A Lee, Hyoun-Ah Kim, et al.
Journal of Clinical Medicine|May 14, 2022
Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus ErythematosusJu-Yang Jung, Hyun-Young Lee, Eunyoung Lee, et al.
Clinical and Experimental Rheumatology|April 24, 2020
Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO RegistryJung Hee Koh, Sun-Kyung Lee, Jinhyun Kim, et al.
International Journal of Molecular Sciences|April 8, 2015
The relevance of miRNA-21 in HSV-induced inflammation in a mouse modelBunsoon Choi, Hyoun-Ah Kim, Chang-Hee Suh, et al.
The Korean Journal of Internal Medicine|November 30, 2023
Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritisHyemin Kim, Soyoung Lee, Ji-Won Kim, et al.
Frontiers in Medicine|July 2, 2021
Comparison of Retention Rates Between Tumor Necrosis Factor-α Inhibitors in Patients With Ankylosing Spondylitis: Data From the Korean College of Rheumatology Biologics RegistryHyoun-Ah Kim, Sun-Kyung Lee, Sohee Oh, et al.
Scientific Reports|November 4, 2021
Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitisSe Hee Kim, Hae-Rim Kim, Sang-Heon Lee, et al.
Pageof 18

Showing results (61-70 of 171) with videos related to

Sort By:
Pageof 18
Rheumatology International|March 31, 2010
Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosusHyoun-Ah Kim, Jun-Mo Sung, Ja-Young Jeon, et al.
The Journal of Rheumatology|September 17, 2009
C-reactive protein gene polymorphisms in disease susceptibility and clinical manifestations of Korean systemic lupus erythematosusHyoun-Ah Kim, Hye-Young Chun, Seung-Hyun Kim, et al.
Scientific Reports|December 8, 2019
Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosusWook-Young Baek, Ji-Min Woo, Hyoun-Ah Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 29, 2022
Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO RegistryJi-Won Kim, Eunyoung A Lee, Hyoun-Ah Kim, et al.
Journal of Clinical Medicine|May 14, 2022
Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus ErythematosusJu-Yang Jung, Hyun-Young Lee, Eunyoung Lee, et al.
Clinical and Experimental Rheumatology|April 24, 2020
Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO RegistryJung Hee Koh, Sun-Kyung Lee, Jinhyun Kim, et al.
International Journal of Molecular Sciences|April 8, 2015
The relevance of miRNA-21 in HSV-induced inflammation in a mouse modelBunsoon Choi, Hyoun-Ah Kim, Chang-Hee Suh, et al.
The Korean Journal of Internal Medicine|November 30, 2023
Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritisHyemin Kim, Soyoung Lee, Ji-Won Kim, et al.
Frontiers in Medicine|July 2, 2021
Comparison of Retention Rates Between Tumor Necrosis Factor-α Inhibitors in Patients With Ankylosing Spondylitis: Data From the Korean College of Rheumatology Biologics RegistryHyoun-Ah Kim, Sun-Kyung Lee, Sohee Oh, et al.
Scientific Reports|November 4, 2021
Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitisSe Hee Kim, Hae-Rim Kim, Sang-Heon Lee, et al.
Pageof 18